WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, July 26, 2006, 26(30):7839-7848; doi:10.1523/JNEUROSCI.1624-06.2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Sidman, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Sidman, R. L.

 Previous Article  |  Next Article 

Neurobiology of Disease
Neural Stem Cells Rescue nervous Purkinje Neurons by Restoring Molecular Homeostasis of Tissue Plasminogen Activator and Downstream Targets

Jianxue Li,1 Jaime Imitola,2 Evan Y. Snyder,3 and Richard L. Sidman1

1Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, 2Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, and 3Stem Cell and Regeneration Program, the Burnham Institute for Medical Research, La Jolla, California 92037

Correspondence should be addressed to either of the following: Richard L. Sidman, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 77 Avenue Louis Pasteur, Harvard Institutes of Medicine 838, Boston, MA 02115, richard_sidman{at}hms.harvard.edu; or Evan Y. Snyder, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, esnyder{at}burnham.org

Neural stem cells (NSCs) offer special therapeutic prospects because they can be isolated from the CNS, expanded ex vivo, and re-implanted into diseased CNS where they not only migrate and differentiate according to cues from host tissue but also appear to be capable of affecting host cells. In nervous (nr) mutant mice Purkinje neuron (PN) mitochondria become abnormal by the second postnatal week, and a majority of PNs die in the fourth to fifth weeks. We previously identified in nr cerebellum a 10-fold increase in tissue plasminogen activator (tPA) as a key component of the mechanism causing nr PN death. Here we report that undifferentiated wild-type murine NSCs, when transplanted into the newborn nr cerebellar cortex, do not replace host PNs but contact imperiled PNs and support their mitochondrial function, dendritic growth, and synaptogenesis, subsequently leading to the rescue of host PNs and restoration of motor coordination. This protection of nr PNs also is verified by an in vitro organotypic slice model in which nr cerebellar slices are cocultured with NSCs. Most importantly, the integrated NSCs in young nr cerebellum rectify excessive tPA mRNA and protein to close to normal levels and protect the mitochondrial voltage-dependent anion channel and neurotrophins, downstream targets of the tPA/plasmin proteolytic system. This report demonstrates for the first time that NSCs can rescue imperiled host neurons by rectifying their gene expression, elevating somatic stem cell therapeutic potential beyond solely cell replacement strategy.

Key words: neural stem cell; Purkinje neuron degeneration; cell rescue; tissue plasminogen activator; mitochondria; neurotrophin

Received April 14, 2006; revised June 17, 2006; accepted June 20, 2006.

Correspondence should be addressed to either of the following: Richard L. Sidman, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 77 Avenue Louis Pasteur, Harvard Institutes of Medicine 838, Boston, MA 02115, richard_sidman{at}hms.harvard.edu; or Evan Y. Snyder, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037, esnyder{at}burnham.org


Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2006 26: i. [Full Text]  



This article has been cited by other articles:


Home page
 Arch NeurolHome page
O. Einstein and T. Ben-Hur
The Changing Face of Neural Stem Cell Therapy in Neurologic Diseases
Arch Neurol, April 1, 2008; 65(4): 452 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. E. Redmond Jr., K. B. Bjugstad, Y. D. Teng, V. Ourednik, J. Ourednik, D. R. Wakeman, X. H. Parsons, R. Gonzalez, B. C. Blanchard, S. U. Kim, et al.
From the Cover: Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells
PNAS, July 17, 2007; 104(29): 12175 - 12180.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Corti, F. Locatelli, D. Papadimitriou, R. Del Bo, M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, F. Fortunato, S. Strazzer, et al.
Neural stem cells LewisX + CXCR4 + modify disease progression in an amyotrophic lateral sclerosis model
Brain, May 1, 2007; 130(5): 1289 - 1305.
[Abstract] [Full Text] [PDF]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-